Tricuspid Regurgitation Study

Overview

About this study

The effect of cardiac pacing leads on tricuspid regurgitation is unclear. This study will determine whether using a smaller diameter leads and an alternate position in the ventricle, the proximal septum, will reduce tricuspid regurgitation than larger leads placed in the apex.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Study closed to enrollment

Inclusion Criteria:

At least 18 years of age of either sex
Patient is recommended to receive a pacemaker or an ICD
Provide informed consent

Exclusion Criteria:

Pregnant or breastfeeding women
Congenital heart disease
Pre-existing moderate or severe TR
An existing pacemaker or defibrillator
Pulmonary hypertension
Pacemaker dependence
Unable to give informed consent
Not feasible for patient to be followed up at Mayo Clinic
Acute myocardial infarction within 7 days

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Yongmei Cha, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Yongmei Cha, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials